Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Gavin Whitlock

1PUBLICATIONS

9CO-AUTHORS

Haematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Feb 23, 2026

A Novel Potent and Selective GCN2 Inhibitor, APL-4098, Has Antileukemic Activity through Dysregulation of Mitochondrial Function.

Monica Román-Trufero, Gavin Whitlock, Claire Seydoux

Pageof 1

Frequent Collaborators

1 joint publications

Monica Román-Trufero

1 joint publications

Claire Seydoux

1 joint publications

Kevin Blighe

1 joint publications

Bianca Perfler

1 joint publications

Armin Zebisch

1 joint publications

Richard Butt

1 joint publications

Matthew J Fuchter

1 joint publications

Holger W Auner

1 joint publications

Nadine Clemo

Frequent Collaborators

1 joint publications

Monica Román-Trufero

1 joint publications

Claire Seydoux

1 joint publications

Kevin Blighe

1 joint publications

Bianca Perfler

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos